# Enhancing PTSD Treatment Outcomes by Improving Patient-Provider Communication

> **NIH MH K23** · BOSTON UNIVERSITY MEDICAL CAMPUS · 2026 · $188,792

## Abstract

Project Summary/Abstract
Posttraumatic stress disorder (PTSD) is a debilitating condition with deleterious effects on individuals and
society. Evidence-based treatments for PTSD are available, including cognitive processing therapy (CPT) and
prolonged exposure (PE), but response rates are suboptimal, and dropout rates are high. Patients report
concerns about treatment that prevent optimal response, but evidence suggests therapists are often unaware of
patients' concerns and do not intervene effectively to help their patients benefit from treatment. The purpose of
this research is to refine and test an Adjunctive Writing intervention for Amplifying Response and Engagement
(AWARE), which was developed to enhance outcomes in CPT and PE. AWARE integrates findings from the field
of health communication and uses a writing task and guided therapist responses to facilitate improved patient-
therapist communication about patients’ treatment-related concerns during existing check-ins in CPT and PE.
After iteratively refining AWARE through a case series (n=4), a pilot randomized controlled trial (n=50) will be
conducted to preliminarily compare CPT/PE with AWARE to CPT/PE treatment as usual (TAU). The primary aim
of the RCT is to take an experimental therapeutics approach to demonstrate that AWARE is feasible, acceptable,
and engages the target of improved patient-therapist communication relative to TAU. A preliminary examination
will also be conducted of the effects of 1) AWARE vs. TAU, and 2) variability in patient-therapist communication
on symptom improvement and treatment completion. An exploratory aim is to examine patient-therapist
communication as a mechanism of improved symptom reduction and attendance in AWARE using session-by-
session assessments to see if the putative mechanism precedes and predicts the outcomes. This trial is
consistent with NIMH's Strategy 3.1.A, "Developing novel interventions using a mechanism-informed,
experimental therapeutics approach," and 

## Key facts

- **NIH application ID:** 11286818
- **Project number:** 5K23MH132815-03
- **Recipient organization:** BOSTON UNIVERSITY MEDICAL CAMPUS
- **Principal Investigator:** Elizabeth Rose Alpert
- **Activity code:** K23 (R01, R21, SBIR, etc.)
- **Funding institute:** MH
- **Fiscal year:** 2026
- **Award amount:** $188,792
- **Award type:** 5
- **Project period:** 2024-03-07T00:00:00 → 2029-02-28T00:00:00

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11286818

## Citation

> US National Institutes of Health, RePORTER application 11286818, Enhancing PTSD Treatment Outcomes by Improving Patient-Provider Communication (5K23MH132815-03). Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/grant/nih/11286818. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*